SEC Form 4 · accession 0000899243-15-001066
aTYR PHARMA INC · LIFE
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Srinivas Akkaraju
Director
Period of report
Jul 8, 2015
Accepted (ET)
Jul 10, 2015 · 6:50 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001339970
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $14.96 | Jul 8, 2015 | A | 6,286 | A | — | Jul 8, 2025 | Common Stock | 6,286 | 6,286 | D |
Explanation of responses
- F1Such Option shall vest on the earlier of (i) the first anniversary of the grant date or (ii) the date of the next annual meeting of the stockholders (currently scheduled for May 2016).